Cited by 15

The DOI matches its Crossref record.

Characterization of a naturally occurring degradation product of the LDL receptor

Tveten, Kristian, Strøm, Thea Bismo, Cameron, Jamie, Holla, Øystein L., Berge, Knut Erik, Leren, Trond P.·2012·Molecular Genetics and Metabolism

Abstract

In this study we have characterized a naturally occurring truncated form of the low density lipoprotein receptor (LDLR). Western blot analysis of transfected cells indicated that the truncated form (∆N-LDLR) is a degradation product of the full-length LDLR generated by cleavage in the linker region between ligand-binding repeats 4 and 5 of the ligand-binding domain. The cleavage of the linker was not caused by components of the culture media, as heat inactivation of the media did not prevent cleavage. Rather, it is assumed that cleavage was caused by an enzyme secreted from the cells. Biotinylation experiments showed that ∆N-LDLR is located on the cell surface and is detectable approximately 5 h after synthesis of the full-length LDLR. Flow cytometric analysis showed that ∆N-LDLR was not able to bind and internalize low density lipoprotein (LDL). ∆N-LDLR appeared to be equally stable as the full-length LDLR. Thus, generation of ∆N-LDLR does not appear to be the first signal for degradation of the LDLR. The existence of two functionally different populations of LDLRs on the cell surface, of which ∆N-LDLR constitutes 28%, must be taken into account when interpreting results of experiments to study LDLRs on the cell surface. Furthermore, if the cleavage of the linker between ligand-binding repeats 4 and 5 could be prevented by an enzyme inhibitor, this could represent a novel therapeutic strategy to increase the number of functioning LDLRs and thereby decrease the levels of plas…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ymgme.2011.10.008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The LDLR is cleaved in the linker region between LA repeat 4 and 5, with Asp193 being crucial for this cleavage.

    “Multiple studies have shown that the LDLR is cleaved in the linker region between LA repeat 4 and 5 [107], with Asp193 being crucial for this cleavage [56,106].”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 20

  1. Südhof, 1985, The LDL receptor gene: a mosaic of exons shared with different proteins, Science, 228, 815, 10.1126/science.2988123 · DOI · Paper page
  2. Yamamoto, 1984, The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA, Cell, 39, 27, 10.1016/0092-8674(84)90188-0 · DOI · Paper page
  3. Tolleshaug, 1982, Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia, Cell, 30, 715, 10.1016/0092-8674(82)90276-8 · DOI · Paper page
  4. Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311 · DOI · Paper page
  5. Rudenko, 2002, Structure of the LDL receptor extracellular domain at endosomal pH, Science, 298, 2353, 10.1126/science.1078124 · DOI · Paper page
  6. Brown, 1983, Recycling receptors: the round-trip itinerary of migrant membrane proteins, Cell, 32, 663, 10.1016/0092-8674(83)90052-1 · DOI · Paper page
  7. Brown, 1997, LDL-receptor structure. Calcium cages, acid baths and recycling receptors, Nature, 388, 629, 10.1038/41672 · DOI · Paper page
  8. Mousavi, 2009, The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis, J. Intern. Med., 266, 507, 10.1111/j.1365-2796.2009.02167.x · DOI
  9. Seidah, 2003, Proc. Natl. Acad. Sci. USA, 100, 928, 10.1073/pnas.0335507100 · DOI · Paper page
  10. Lehrman, 1985, Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain, Cell, 41, 735, 10.1016/S0092-8674(85)80054-4 · DOI
  11. Webb, 1992, Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia, J. Lipid Res., 33, 689, 10.1016/S0022-2275(20)41433-6 · DOI
  12. Strøm, 2010, Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes, Clin. Chim. Acta, 411, 229, 10.1016/j.cca.2009.11.008 · DOI
  13. Sørensen, 2006, Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress, J. Biol. Chem., 281, 468, 10.1074/jbc.M507071200 · DOI
  14. Tveten, 2007, 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor, FEBS J., 274, 1881, 10.1111/j.1742-4658.2007.05735.x · DOI
  15. Cameron, 2006, Effect of mutations in the PCSK9 gene on the cell surface LDL receptors, Hum. Mol. Genet., 15, 1551, 10.1093/hmg/ddl077 · DOI · Paper page
  16. Tveten, 2009, The effect of bafilomycin A1 and protease inhibitors on the degradation and recycling of a Class 5-mutant LDLR, Acta Biochim. Biophys. Sin., 4, 246, 10.1093/abbs/gmp008 · DOI
  17. Pitas, 1981, Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy, Arteriosclerosis, 1, 177, 10.1161/01.ATV.1.3.177 · DOI
  18. Russell, 1989, Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins, J. Biol. Chem., 264, 21682, 10.1016/S0021-9258(20)88240-4 · DOI · Paper page
  19. Holla, 2011, Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors, J. Lipid Res., 52, 1787, 10.1194/jlr.M018093 · DOI · Paper page
  20. Zhang, 2008, Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor, Proc. Natl. Acad. Sci. USA, 105, 13045, 10.1073/pnas.0806312105 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Tveten, K., Strøm, T. B., Cameron, J., Holla, Ø. L., Berge, K. E., & Leren, T. P.
Venue
Molecular Genetics and Metabolism
Publisher
Elsevier BV
Published
2012-01
Volume
105
Issue
1
Pages
149-154
ISSN
1096-7192
Cited by
15
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review